Fabbri, Margherita
Inserm · Centre Hospitalier Universitaire de Toulouse · French Clinical Research Infrastructure Network · Centre d’Investigation Clinique 1436 · Université de Toulouse
2 papers on CoChatORCID 0000-0001-7250-592X
Most cited papers
- Verified
Trial of Lixisenatide in Early Parkinson’s Disease
Meissner, W. G., Remy, P., Giordana, C., Maltête, D., Derkinderen, P., Houéto, J.-L., Anheim, M., Benatru, I., Boraud, T., Brefel-Courbon, C., et al. (2024) · New England Journal of Medicine
Parkinson's Disease Mechanisms and TreatmentsDeep Brain Stimulation and Movement Disorders
Cited by 369
- Verified
Gut Microbiota and Metabolome Distinctive Features in Parkinson Disease: Focus on Levodopa and Levodopa-carbidopa Intrajejunal Gel
Melis, M., Vascellari, S., Santoru, M. L., Oppo, V., Fabbri, M., Sarchioto, M., Murgia, D., Zibetti, M., Lopiano, L., Serra, A., et al. (2021) · European Journal of Neurology
Gut microbiota and healthParkinson's Disease Mechanisms and Treatments
Cited by 37
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free